Skip to main content
Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
46.58
-0.31 (-0.66%)
At close: Nov 20, 2024, 4:00 PM
45.00
-1.58 (-3.39%)
Pre-market: Nov 21, 2024, 5:25 AM EST

Tarsus Pharmaceuticals Revenue

Tarsus Pharmaceuticals had revenue of $48.12M in the quarter ending September 30, 2024, with 2,471.78% growth. This brings the company's revenue in the last twelve months to $129.62M, up 801.96% year-over-year. In the year 2023, Tarsus Pharmaceuticals had annual revenue of $17.45M, down -32.42%.

Revenue (ttm)
$129.62M
Revenue Growth
+801.96%
P/S Ratio
13.04
Revenue / Employee
$531,234
Employees
244
Market Cap
1.78B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202317.45M-8.37M-32.42%
Dec 31, 202225.82M-31.21M-54.73%
Dec 31, 202157.03M--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fortrea Holdings 2.98B
Integra LifeSciences Holdings 1.56B
Tandem Diabetes Care 854.35M
NovoCure 577.74M
AtriCure 447.57M
Galapagos NV 290.09M
RxSight 128.29M
Recursion Pharmaceuticals 65.18M
Revenue Rankings

TARS News

More News